Bids Are Invited For Ppta 202-26 Adq Sensors Monitoring Cont. Glucose

These Bases Refer To The Conditions And Technical Characteristics Required For The “Acquisition Of Continuous Glucose Monitoring Sensors For Patients With Diabetes Mellitus Type 1 Under 18 Years Of Age And Pregnant Women With Dm1”, Hereinafter: “The Inputs”, For The Period Of Twelve 12 Months. Type 1 Diabetes Mellitus Is A Chronic Pathology That Requires Strict And Permanent Glycemic Control To Prevent Acute Complications, Severe And Chronic Hypoglycemia And Hyperglycemia. In The Case Of Pediatric Patients And Pregnant Women With Dm1, Continuous Glucose Monitoring Constitutes A Fundamental Tool To Optimize Metabolic Control, Reduce Clinical Risks And Improve Health Outcomes, Especially In The Context Of Pregnancy, Where Adequate Glycemic Control Significantly Reduces Maternal-Fetal Complications. Likewise, The Provision Of These Devices Is Part Of The Explicit Ges Health Guarantees, Ensuring Continuity Of Treatment, Timeliness Of Care And Compliance With Current Clinical Standards. The Acquisition Will Be Carried Out In Accordance With The Annual Purchasing Plan 2026 Pac 2026, Current Legislation, Administrative And Technical Bases, Technical Specifications Detailed In Annex No. 3 And Among Others That Constitute The Required Call For Bids.